Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Antibacterial Cross-Monograph Ingredients, Indications Urged By CTFA/SDA

This article was originally published in The Tan Sheet

Executive Summary

Combination indications for antimicrobial products formulated with active ingredients from the first aid monograph or skin protectant monograph should be allowed by FDA, industry groups advise in a June 1 citizen petition.

You may also be interested in...



Antimicrobial Data Support CTFA/SDA Performance Criteria - Petition

A comprehensive literature review of topical antimicrobial data "corroborates" the suitability of the product performance criteria advocated by industry, the Cosmetic, Toiletry & Fragrance Association and Soap & Detergent Association maintain in an Aug. 6 joint submission to FDA.

Antimicrobial Data Support CTFA/SDA Performance Criteria - Petition

A comprehensive literature review of topical antimicrobial data "corroborates" the suitability of the product performance criteria advocated by industry, the Cosmetic, Toiletry & Fragrance Association and Soap & Detergent Association maintain in an Aug. 6 joint submission to FDA.

Antimicrobial Data Support CTFA/SDA Performance Criteria - Petition

A comprehensive literature review of topical antimicrobial data "corroborates" the suitability of the product performance criteria advocated by industry, the Cosmetic, Toiletry & Fragrance Association and Soap & Detergent Association maintain in an Aug. 6 joint submission to FDA.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092638

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel